Bausch + Lomb (BLCO) Revenue & Revenue Breakdown
Bausch + Lomb Revenue Highlights
Latest Revenue (Y)
$5.08B
Latest Revenue (Q)
$1.28B
Main Segment (Y)
Device Products
Main Geography (Y)
United States and Puerto Rico
Bausch + Lomb Revenue by Period
Bausch + Lomb Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $5.08B | 6.03% |
| 2024-12-31 | $4.79B | 15.56% |
| 2023-12-31 | $4.15B | 10.03% |
| 2022-12-31 | $3.77B | 0.08% |
| 2021-12-31 | $3.77B | 10.35% |
| 2020-12-31 | $3.41B | -9.69% |
| 2019-12-31 | $3.78B | 3.08% |
| 2018-12-31 | $3.67B | - |
Bausch + Lomb generated $5.08B in revenue during NA 2025, up 6.03% compared to the previous quarter, and up 148.89% compared to the same period a year ago.
Bausch + Lomb Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $1.28B | -0.08% |
| 2025-06-30 | $1.28B | 12.80% |
| 2025-03-31 | $1.13B | -11.48% |
| 2024-12-31 | $1.28B | 7.02% |
| 2024-09-30 | $1.20B | -1.64% |
| 2024-06-30 | $1.22B | 10.65% |
| 2024-03-31 | $1.10B | -6.31% |
| 2023-12-31 | $1.17B | 16.48% |
| 2023-09-30 | $1.01B | -2.71% |
| 2023-06-30 | $1.03B | 11.17% |
| 2023-03-31 | $931.00M | -6.53% |
| 2022-12-31 | $996.00M | 5.73% |
| 2022-09-30 | $942.00M | 0.11% |
| 2022-06-30 | $941.00M | 5.85% |
| 2022-03-31 | $889.00M | -11.19% |
| 2021-12-31 | $1.00B | 5.48% |
| 2021-09-30 | $949.00M | 1.61% |
| 2021-06-30 | $934.00M | 6.02% |
| 2021-03-31 | $881.00M | -6.67% |
| 2020-12-31 | $944.00M | 3.06% |
| 2020-09-30 | $916.00M | 18.04% |
| 2020-06-30 | $776.00M | - |
| 2020-03-31 | $776.00M | - |
Bausch + Lomb generated $1.28B in revenue during Q3 2025, up -0.08% compared to the previous quarter, and up 105.02% compared to the same period a year ago.
Bausch + Lomb Revenue Breakdown
Bausch + Lomb Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Over the Counter Products | $1.83B | $1.72B | $1.61B | - |
| Pharmaceutical Products | $1.08B | $969.00M | $618.00M | - |
| Branded and Other Generic Products | $243.00M | $281.00M | $252.00M | - |
| Device Products | $1.92B | $1.80B | $1.65B | - |
| Other Revenues | $21.00M | $17.00M | $15.00M | - |
| Product and Service, Other | - | - | - | $22.00M |
| Product | - | - | - | $3.75B |
Bausch + Lomb's latest annual revenue breakdown by segment (product or service), as of Dec 25: Device Products (37.68%), Over the Counter Products (35.95%), Pharmaceutical Products (21.19%), Branded and Other Generic Products (4.76%), and Other Revenues (0.41%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Revenues | $7.00M | $4.00M | $6.00M | $4.00M | $5.00M | $4.00M | $3.00M | $5.00M | $12.00M | $3.00M | - | - | - | - | - | - |
| Branded and Other Generic Products | $72.00M | $59.00M | $58.00M | $54.00M | $69.00M | $70.00M | $76.00M | $66.00M | $180.00M | $72.00M | - | - | - | - | - | - |
| Pharmaceutical Products | $319.00M | $280.00M | $260.00M | $222.00M | $268.00M | $247.00M | $245.00M | $209.00M | $505.00M | $113.00M | - | - | - | - | - | - |
| Over the Counter Products | $489.00M | $454.00M | $482.00M | $409.00M | $462.00M | $420.00M | $447.00M | $395.00M | $1.20B | $408.00M | - | - | - | - | - | - |
| Device Products | $518.00M | $484.00M | $472.00M | $448.00M | $476.00M | $455.00M | $445.00M | $424.00M | $1.24B | $411.00M | - | - | - | - | - | - |
| Product and Service, Other | - | - | - | - | - | - | - | - | - | - | $4.00M | $3.00M | $5.00M | $5.00M | $6.00M | $6.00M |
| Product | - | - | - | - | - | - | - | - | - | - | $1.03B | $928.00M | $991.00M | $937.00M | $935.00M | $883.00M |
Bausch + Lomb's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Device Products (36.87%), Over the Counter Products (34.80%), Pharmaceutical Products (22.70%), Branded and Other Generic Products (5.12%), and Other Revenues (0.50%).
Bausch + Lomb Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| SPAIN | $101.00M | $92.00M | $85.00M | $77.00M |
| FRANCE | $246.00M | $227.00M | $210.00M | $195.00M |
| POLAND | $75.00M | $65.00M | $51.00M | $44.00M |
| Other Countries | $777.00M | $759.00M | $655.00M | $572.00M |
| MEXICO | $75.00M | $75.00M | $68.00M | $55.00M |
| KOREA, REPUBLIC OF | $51.00M | $46.00M | $44.00M | - |
| JAPAN | $186.00M | $180.00M | $187.00M | $192.00M |
| ITALY | $102.00M | $91.00M | $82.00M | $72.00M |
| GERMANY | $164.00M | $152.00M | $147.00M | $138.00M |
| United States and Puerto Rico | $2.55B | $2.41B | $1.93B | $1.70B |
| CANADA | $135.00M | $127.00M | $110.00M | $101.00M |
| CHINA | $358.00M | $358.00M | $344.00M | $343.00M |
Bausch + Lomb's latest annual revenue breakdown by geography, as of Dec 25: United States and Puerto Rico (52.87%), Other Countries (16.13%), CHINA (7.43%), FRANCE (5.11%), JAPAN (3.86%), GERMANY (3.41%), CANADA (2.80%), ITALY (2.12%), SPAIN (2.10%), POLAND (1.56%), MEXICO (1.56%), and KOREA, REPUBLIC OF (1.06%).
Quarterly Revenue by Country
| Country | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FRANCE | $51.00M | $52.00M | $64.00M | $60.00M | $45.00M | $47.00M | $62.00M | $56.00M | $41.00M | $43.00M | $56.00M | $55.00M |
| ITALY | $23.00M | $22.00M | $23.00M | $23.00M | $21.00M | $19.00M | $22.00M | $20.00M | $15.00M | $16.00M | $21.00M | $20.00M |
| JAPAN | $50.00M | $45.00M | $43.00M | $42.00M | $48.00M | $45.00M | $46.00M | $48.00M | $49.00M | $46.00M | $47.00M | $50.00M |
| MEXICO | $20.00M | $18.00M | $20.00M | $17.00M | $18.00M | $19.00M | $15.00M | $16.00M | $16.00M | $14.00M | $14.00M | $11.00M |
| Other Countries | $244.00M | $174.00M | $175.00M | $166.00M | $214.00M | $150.00M | $152.00M | $139.00M | $157.00M | $142.00M | $138.00M | $126.00M |
| POLAND | $15.00M | $17.00M | $18.00M | $15.00M | $14.00M | $11.00M | $14.00M | $12.00M | $11.00M | $10.00M | $12.00M | $11.00M |
| SPAIN | $26.00M | $20.00M | $25.00M | $21.00M | $23.00M | $18.00M | $24.00M | $20.00M | $21.00M | $15.00M | $22.00M | $19.00M |
| United States and Puerto Rico | $657.00M | $609.00M | $610.00M | $537.00M | $593.00M | $471.00M | $466.00M | $404.00M | $454.00M | $425.00M | $430.00M | $386.00M |
| CANADA | $34.00M | $33.00M | $32.00M | $28.00M | $30.00M | $27.00M | $27.00M | $26.00M | $28.00M | $27.00M | $24.00M | $22.00M |
| CHINA | $96.00M | $92.00M | $93.00M | $77.00M | $94.00M | $87.00M | $89.00M | $74.00M | $92.00M | $93.00M | $76.00M | $82.00M |
| GERMANY | $32.00M | $38.00M | $40.00M | $42.00M | $32.00M | $33.00M | $40.00M | $42.00M | $32.00M | $30.00M | $33.00M | $43.00M |
| KOREA, REPUBLIC OF | - | $12.00M | $11.00M | $12.00M | $11.00M | $12.00M | $12.00M | $11.00M | $11.00M | $11.00M | $11.00M | $11.00M |
| AUSTRALIA | - | - | - | - | - | $11.00M | $11.00M | $10.00M | - | - | - | - |
| SWEDEN | - | - | - | - | - | - | - | - | - | - | - | $9.00M |
Bausch + Lomb's latest quarterly revenue breakdown by geography, as of Dec 24: United States and Puerto Rico (52.64%), Other Countries (19.55%), CHINA (7.69%), FRANCE (4.09%), JAPAN (4.01%), CANADA (2.72%), GERMANY (2.56%), SPAIN (2.08%), ITALY (1.84%), MEXICO (1.60%), and POLAND (1.20%).
Bausch + Lomb Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OSCR | Oscar Health | $11.70B | $2.99B |
| BLCO | Bausch + Lomb | $5.08B | $1.28B |
| TFX | Teleflex | $1.99B | $913.02M |
| PTCT | PTC Therapeutics | $1.73B | $211.01M |
| MMSI | Merit Medical Systems | $1.52B | $384.16M |
| ARWR | Arrowhead Pharmaceuticals | $829.45M | $264.03M |
| TGTX | TG Therapeutics | $616.29M | $161.71M |
| GKOS | Glaukos | $383.48M | $133.54M |
| CRSP | CRISPR Therapeutics | $3.51M | $889.00K |
| PCVX | Vaxcyte | - | - |
| ACLX | Arcellx | - | $7.55M |